[Current approaches to prevention and treatment of antiphospholipid syndrome].
Nasonov
E L
EL
D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D003276:Contraceptives, Oral / Q000009:adverse effects; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006886:Hydroxychloroquine / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D013997:Time Factors; D014859:Warfarin / Q000008:administration & dosage / Q000627:therapeutic use
D000925:Anticoagulants; D003276:Contraceptives, Oral; D004791:Enzyme Inhibitors; D005938:Glucocorticoids; D006495:Heparin, Low-Molecular-Weight; D010975:Platelet Aggregation Inhibitors; D006886:Hydroxychloroquine; D014859:Warfarin; D001241:Aspirin